Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel +/-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma

A. P. Barbour, E. T. Walpole, G. T. Mai, L. Barnes, D. I. Watson, S. P. Ackland, V. Wills, J. Martin, M. Burge, C. S. Karapetis, J. Shannon, L. M. Nott, V. Gebski, M. Oostendorp, K. Wilson, J. Thomas, G. Lampe, J. R. Zalcberg, J. Simes, M. Smithers

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel +/-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science